Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Development and characterization of a Zaire Ebola (ZEBOV) specific IgM ELISA.

Atre T, Phillips RL, Modjarrad K, Regules JA, Bergmann-Leitner ES.

J Immunol Methods. 2019 May;468:29-34. doi: 10.1016/j.jim.2019.03.008. Epub 2019 Mar 22.

PMID:
30910536
2.

Mosquito Bite-Induced Controlled Human Malaria Infection with Plasmodium vivax or P. falciparum Generates Immune Responses to Homologous and Heterologous Preerythrocytic and Erythrocytic Antigens.

Hall CE, Hagan LM, Bergmann-Leitner E, Tosh DM, Bennett JW, Regules JA, Chuang I, Angov E, Dutta S, Chattopadhyay D, Yadava A.

Infect Immun. 2019 Feb 21;87(3). pii: e00541-18. doi: 10.1128/IAI.00541-18. Print 2019 Mar.

3.

RTS,S malaria vaccine efficacy and immunogenicity during Plasmodium falciparum challenge is associated with HLA genotype.

Nielsen CM, Vekemans J, Lievens M, Kester KE, Regules JA, Ockenhouse CF.

Vaccine. 2018 Mar 14;36(12):1637-1642. doi: 10.1016/j.vaccine.2018.01.069. Epub 2018 Feb 10.

4.

Delayed fractional dose regimen of the RTS,S/AS01 malaria vaccine candidate enhances an IgG4 response that inhibits serum opsonophagocytosis.

Chaudhury S, Regules JA, Darko CA, Dutta S, Wallqvist A, Waters NC, Jongert E, Lemiale F, Bergmann-Leitner ES.

Sci Rep. 2017 Aug 11;7(1):7998. doi: 10.1038/s41598-017-08526-5.

5.

Circulating follicular T helper cells and cytokine profile in humans following vaccination with the rVSV-ZEBOV Ebola vaccine.

Farooq F, Beck K, Paolino KM, Phillips R, Waters NC, Regules JA, Bergmann-Leitner ES.

Sci Rep. 2016 Jun 21;6:27944. doi: 10.1038/srep27944.

6.

Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study.

Regules JA, Cicatelli SB, Bennett JW, Paolino KM, Twomey PS, Moon JE, Kathcart AK, Hauns KD, Komisar JL, Qabar AN, Davidson SA, Dutta S, Griffith ME, Magee CD, Wojnarski M, Livezey JR, Kress AT, Waterman PE, Jongert E, Wille-Reece U, Volkmuth W, Emerling D, Robinson WH, Lievens M, Morelle D, Lee CK, Yassin-Rajkumar B, Weltzin R, Cohen J, Paris RM, Waters NC, Birkett AJ, Kaslow DC, Ballou WR, Ockenhouse CF, Vekemans J.

J Infect Dis. 2016 Sep 1;214(5):762-71. doi: 10.1093/infdis/jiw237. Epub 2016 Jun 13.

PMID:
27296848
7.

The biological function of antibodies induced by the RTS,S/AS01 malaria vaccine candidate is determined by their fine specificity.

Chaudhury S, Ockenhouse CF, Regules JA, Dutta S, Wallqvist A, Jongert E, Waters NC, Lemiale F, Bergmann-Leitner E.

Malar J. 2016 May 31;15:301. doi: 10.1186/s12936-016-1348-9.

8.

Immunology of protection from Ebola virus infection.

Krause PR, Bryant PR, Clark T, Dempsey W, Henchal E, Michael NL, Regules JA, Gruber MF.

Sci Transl Med. 2015 May 6;7(286):286ps11. doi: 10.1126/scitranslmed.aaa8202. Review.

PMID:
25947159
9.

A Recombinant Vesicular Stomatitis Virus Ebola Vaccine.

Regules JA, Beigel JH, Paolino KM, Voell J, Castellano AR, Hu Z, Muñoz P, Moon JE, Ruck RC, Bennett JW, Twomey PS, Gutiérrez RL, Remich SA, Hack HR, Wisniewski ML, Josleyn MD, Kwilas SA, Van Deusen N, Mbaya OT, Zhou Y, Stanley DA, Jing W, Smith KS, Shi M, Ledgerwood JE, Graham BS, Sullivan NJ, Jagodzinski LL, Peel SA, Alimonti JB, Hooper JW, Silvera PM, Martin BK, Monath TP, Ramsey WJ, Link CJ, Lane HC, Michael NL, Davey RT Jr, Thomas SJ; rVSVΔG-ZEBOV-GP Study Group.

N Engl J Med. 2017 Jan 26;376(4):330-341. doi: 10.1056/NEJMoa1414216. Epub 2015 Apr 1.

10.

The RTS,S vaccine candidate for malaria.

Regules JA, Cummings JF, Ockenhouse CF.

Expert Rev Vaccines. 2011 May;10(5):589-99. doi: 10.1586/erv.11.57. Review.

PMID:
21604980
11.

Invasive Vibrio cholerae infection following burn injury.

Regules JA, Horvath LL, Chung KK.

J Burn Care Res. 2008 May-Jun;29(3):551-4. doi: 10.1097/BCR.0b013e31817111f6.

PMID:
18388568
12.

Endocarditis in burn patients: clinical and diagnostic considerations.

Regules JA, Glasser JS, Wolf SE, Hospenthal DR, Murray CK.

Burns. 2008 Aug;34(5):610-6. Epub 2007 Oct 29. Review.

PMID:
18029099
13.

Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial.

Ellis MW, Griffith ME, Dooley DP, McLean JC, Jorgensen JH, Patterson JE, Davis KA, Hawley JS, Regules JA, Rivard RG, Gray PJ, Ceremuga JM, Dejoseph MA, Hospenthal DR.

Antimicrob Agents Chemother. 2007 Oct;51(10):3591-8. Epub 2007 Aug 6.

14.

Analysis of anaerobic blood cultures in burned patients.

Regules JA, Carlson MD, Wolf SE, Murray CK.

Burns. 2007 Aug;33(5):561-4. Epub 2007 May 9.

PMID:
17493763
15.

The effect of semipermeable dressings on smallpox vaccine site evolution.

Regules JA, Dooley DP, Hepburn MJ, Van De Car DA, Davis KA, McAllister KC, Hospenthal DR, Murray CK, Fofaria R, Ekstrand JR, Crouch HK.

Am J Infect Control. 2004 Oct;32(6):333-6.

PMID:
15454889

Supplemental Content

Loading ...
Support Center